Feasibility study to inform the design of a randomised controlled trial to eradicate <it>Pseudomonas aeruginosa </it>infection in individuals with Cystic Fibrosis
<p>Abstract</p> <p>Background</p> <p>There are controversies about the most effective treatment to eradicate first growth of <it>Pseudomonas aeruginosa (P aeruginosa) </it>from the lower airways of patients with cystic fibrosis (CF). UK guidelines recommend...
Main Authors: | Lenney Warren, Williamson Paula R, Jones Ashley P, Hickey Helen R, Smyth Rosalind L |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-02-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/11/1/11 |
Similar Items
-
The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
by: Amanda J. Morris, et al.
Published: (2021-08-01) -
No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
by: F. Claude, et al.
Published: (2019-03-01) -
Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
by: Francis J. Gilchrist, et al. -
Comparative Efficacy of Two Doses of Nebulized Colistimethate for the Eradication of Pseudomonas Aeruginosa in Children with Cystic Fibrosis
by: Marie-Sophie Brochet, et al.
Published: (2007-01-01) -
Genetic studies of cystic fibrosis epidemic strains of Pseudomonas aeruginosa
by: Smart, Catherine Helen Mary
Published: (2006)